Saint Paul R&D Tax Credit and Its Benefits to Companies

R&D Tax Credits for Saint Paul, Minnesota Businesses

Saint Paul, Minnesota, thrives in industries such as healthcare, education, government, and retail. Top companies in the city include Regions Hospital, a major healthcare provider; Macalester College, a key educational institution; the State of Minnesota, a prominent government employer; Walmart, a global retail giant; and Amazon, a global logistics and e-commerce company. The R&D Tax Credit can benefit these industries by lowering tax burdens, encouraging innovation, and improving business performance. By leveraging the R&D Tax Credit, companies can reinvest savings into cutting-edge research boosting Saint Paul’s economic growth.

find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 14870 Granada Avenue, Apple Valley, Minnesota is less than 25 miles away from Saint Paul and provides R&D tax credit consulting and advisory services to Saint Paul and the surrounding areas such as: Minneapolis, Rochester, Bloomington, Duluth and Brooklyn Park.

If you have any questions or need further assistance, please call or email our local Minnesota Partner on (952) 236-4344.
Feel free to book a quick teleconference with one of our Minnesota R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Saint Paul, Minnesota Patent of the Year – 2024/2025

Shape Medical Systems Inc. has been awarded the 2024/2025 Patent of the Year for innovation in cardiopulmonary diagnostics. Their invention, detailed in U.S. Patent No. 12023145, titled ‘Gas exchange systems and methods for calculating ventilatory threshold and evaluating pulmonary arterial hypertension’, introduces a more accurate, real-time approach to assessing respiratory and cardiovascular health.

This cutting-edge system analyzes gas exchange during exercise to determine key health markers, including ventilatory threshold and indicators of pulmonary arterial hypertension. By tracking how oxygen and carbon dioxide are processed under stress, the device helps physicians detect early signs of disease and evaluate treatment effectiveness.

The invention uses automated algorithms and streamlined hardware to deliver fast, user-friendly assessments. Unlike older systems that require bulky equipment or manual analysis, this technology offers reliable data in a portable and efficient format. It has the potential to reduce costs, improve patient outcomes, and support earlier diagnoses of serious heart and lung conditions.

Shape Medical Systems’ innovation could change how clinics and hospitals monitor patients with cardiovascular and pulmonary risks. Its real-world impact includes better decision-making during rehabilitation, more personalized care plans, and expanded access to advanced testing in non-hospital settings.

With this patent, Shape Medical Systems reinforces its role as a leader in cardiopulmonary technology, pushing diagnostic tools into a faster, smarter future.